Acasti Pharma
(ACST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACST | SLGL | MGX | ||
| Company | Acasti Pharma | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.38 | 64.80 | 1.5300 | ||
| High | 3.45 | 65.50 | 1.5900 | ||
| Low | 3.20 | 63.57 | 1.5200 | ||
| Latest | 3.37 | 65.00 | 1.5700 | ||
| Change | -0.03 | -0.27 | +0.0400 | ||
| % Change | -0.88% | -0.41% | +2.61% | ||
| Volume | 27,800 | 16,700 | 315,000 | ||
| 20-Day Average Volume | 34,930 | 26,735 | 288,170 | ||
| Previous Close | 3.40 | 65.27 | 1.5300 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.24 | 64.09 | 1.6030 | ||
| 20-Day Raw Stochastic | 72.29% | 62.60% | 43.90% | ||
| 20-Day Relative Strength | 58.39 | 61.39 | 44.97 | ||
| Weighted Alpha | +24.36 | +454.19 | -43.01 | ||
| Today's Opinion | 40% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 40% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 8% Sell | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.20% since 10/18/24 | -1.66% since 02/03/26 | +5.37% since 02/03/26 | ||
| Low | 3.12 on 10/21/24 | 59.00 on 02/04/26 | 1.3900 on 02/06/26 | ||
| High | 3.60 on 10/23/24 | 67.78 on 02/05/26 | 1.5900 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | +10.13% since 09/25/24 | +12.07% since 01/09/26 | -12.29% since 01/09/26 | ||
| Low | 2.77 on 10/01/24 | 48.26 on 01/23/26 | 1.3900 on 02/06/26 | ||
| High | 3.60 on 10/23/24 | 75.00 on 01/21/26 | 1.8000 on 01/23/26 | ||
| 3-Month | |||||
| %Chg | +19.08% since 07/25/24 | +100.43% since 11/10/25 | -26.98% since 11/10/25 | ||
| Low | 2.13 on 09/12/24 | 28.81 on 11/13/25 | 1.3900 on 02/06/26 | ||
| High | 3.60 on 10/23/24 | 75.00 on 01/21/26 | 2.2300 on 11/11/25 | ||
| 6-Month | |||||
| %Chg | +15.08% since 04/25/24 | +306.50% since 08/08/25 | -18.23% since 08/08/25 | ||
| Low | 2.13 on 09/12/24 | 14.78 on 08/14/25 | 1.3900 on 02/06/26 | ||
| High | 3.60 on 10/23/24 | 75.00 on 01/21/26 | 3.9500 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,676 | 181,829 | 57,447 | ||
| Shares Outstanding, K | 9,399 | 2,786 | 37,547 | ||
| Annual Sales | 0 | 11,540,000 | 52,300,000 | ||
| Annual Net Income | -12,850,000 | -10,580,000 | -78,060,000 | ||
| Last Quarter Sales | 0 | 400,000 | 8,660,000 | ||
| Last Quarter Net Income | -2,620,000 | -5,940,000 | -20,390,000 | ||
| 60-Month Beta | 1.52 | 1.35 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/09/24 | -2.13 on 11/20/25 | -0.55 on 11/11/25 | ||
| Latest Earnings Date | 11/11/24 | 05/05/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||